Intrathecal Nicardipine for Subarachnoid Hemorrhage

Created using ChatSlide

This presentation provides a comprehensive overview of subarachnoid hemorrhage (aSAH), emphasizing its causes, patient outcomes, and current management, including the significance of cerebral vasospasm (CVS) and delayed cerebral ischemia (DCI). It highlights intrathecal nicardipine as an emerging treatment, discussing its pharmacology, efficacy based on evidence from studies, and safety profile. Knowledge gaps, optimal protocols, and research opportunities are addressed, alongside practical...